Agenda
Please note: The current Corona regulations and quarantine rules as well as the 2G rule apply to this on-site event (see also here).
We strongly encourage everyone to perform a point-of-care (PoC) antigen test before the event.
Moderator: Dimitrios Wagner, BCRT/BeCAT
|
16.15 |
Registration & Coffee |
||
|
17.00-17.05 |
Jasmin Podufall |
Berlin Partner für Wirtschaft und Technologie GmbH |
Welcome Address |
|
17.05-17.15 |
Dimitrios Wagner |
BCRT & BeCAT |
Evolution of the CRISPR-Cas9 technology |
|
17.15-17.35 |
André Cohnen |
Bayer AG |
Finding
and optimizing novel CRISPR systems – an overview |
|
17.35-17.55 |
Michael Kaminski |
MDC & Charité |
CRISPR-based
diagnostics |
|
17.55-18.15 |
Manuel Kaulich |
Goethe University Frankfurt am Main & Vivlion GmbH |
Combinatorial CRISPR screens to understand malignant cell transformation |
|
|
|
|
|
|
18.15-19.00 |
BREAK |
||
|
19.00-19.20 |
Leila Amini |
BCRT
& BeCAT |
CRISPR-based
immune cell therapies |
|
19.20-19.40 |
Simone Spuler |
MDC & Charité |
CRISPR-based cell therapies for genetic muscle disorders |
|
19.40-20.10 |
Juergen Foell |
University
of Regensburg |
CRISPR-Cas9
Gene Editing for Sickle Cell Disease and β-Thalassemia |
|
20.10-20.20 |
Dimitrios Wagner |
BCRT & BeCAT |
Closing remarks |
|
20.20-21.15 |
Get together & Networking |
